UroGen Pharma (URGN) Revenue (2018 - 2026)
UroGen Pharma (URGN) revenue from Mar 31, 2018 to Mar 31, 2026. The TTM UroGen Pharma (URGN) revenue is $141M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
UroGen Pharma (URGN) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +52.93% |
| 3 Years TTM | +27.38% |
| 5 Years TTM | +48.75% |
| All Time TTM | +116.01% |
Annual Revenue change of UroGen Pharma (URGN)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $51M | -53.58% |
| 2025 | $110M | +21.45% |
| 2024 | $90M | +9.30% |
| 2023 | $83M | +28.51% |
| 2022 | $64M | +33.97% |
| 2021 | $48M | +307.12% |
| 2020 | $12M | +58900.00% |
| 2019 | $20K | -98.23% |
| 2018 | $1.13M | -86.15% |
| 2017 | $8.16M | -53.45% |
| 2016 | $18M | N/A |
| 2015 | $0 | N/A |
Comparison UroGen Pharma (URGN) five years revenue CAGR with competitors
UroGen Pharma (URGN) five years revenue CAGR is 48.76%.